Back to search

Article

<p class="MsoNormal" style="margin-bottom: 12.0pt; text-align: left; mso-line-height-alt: 14.0pt; layout-grid-mode: char; mso-layout-grid-align: none;" align="left"><sup>161</sup>Tb-BPAMD as a High-Affinity Agent for Skeletal Targeting: Radiochemical and Biodistribution Insights

2026-01-12

Abstract excerpt

<h4>Background: </h4> Bone-seeking radiopharmaceuticals based on bisphosphonates enable targeted therapy of skeletal metastases. They are ideal carriers for therapeutic radionuclides such as Terbium-161 (161Tb), a β-emitter that additionally releases short-range conversion and Auger electrons, which may enhance radiation dose delivery to small lesions. This study aimed to investigate the potential of the specific...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8fdc0849-4c09-5efc-a1f4-efb567466d88
DOI
10.20944/preprints202601.0694.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<p class="MsoNormal" style="margin-bottom: 12.0pt; text-align: left; mso-line-height-alt: 14.0pt; layout-grid-mode: char; mso-layout-grid-align: none;" align="left"><sup>161</sup>Tb-BPAMD as a High-Affinity Agent for Skeletal Targeting: Radiochemical and Biodistribution InsightsDOI 10.20944/preprints202601.0694.v1
Select a neighboring publication to make it the new centre.